State-of-the-art infrastructure ensuring quality and compliance
Cerata Pharmaceuticals LLP operates three independent cGMP-compliant API manufacturing facilities with a combined installed capacity exceeding 100 metric tons, dedicated to the manufacturing of Steroid & Hormone, Oncology, and Peptide Active Pharmaceutical Ingredients.
We produce 100s of tons of APIs annually, exporting to over 40 countries and consistently meeting global pharmaceutical needs.
We maintain strict global quality standards, delivering uniform product quality and reliability across all markets. Our facilities are approved by leading regulatory authorities and are trusted by Big Pharma and multinational companies worldwide.
Our commitment to quality is validated by global regulatory approvals and certifications
Meeting World Health Organization Good Manufacturing Practice standards
Globally recognized business identification and verification
Three independent cGMP-compliant manufacturing units with advanced infrastructure and technology for API production.
State-of-the-art R&D facilities dedicated to developing innovative APIs with modern analytical equipment.
Comprehensive quality management system ensuring compliance with global regulatory standards.
Comprehensive hormone and steroid API manufacturing with advanced synthesis techniques.
Specialized oncology API manufacturing with advanced synthesis techniques and targeted therapies.
Peptide API manufacturing using cutting-edge technology for complex molecular structures.